ConductScience.org, home

Paper17417841

Circular DNA and DNA/RNA hybrid molecules as scaffolds for ricin inhibitor design.

Sturm MB and 2 others. J Am Chem Soc, 2007. Cited by 33 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Circular DNA and DNA/RNA hybrid molecules as scaffolds for ricin inhibitor design. Papers, record 17417841. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17417841

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Circular DNA and DNA/RNA hybrid molecules as scaffolds for ricin inhibitor design.
PubMed
Journal
J Am Chem Soc
PubMed
Year
2007
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
33
iCite
Relative citation ratio, by iCite
0.8
iCite
Revised in PubMed
2025-05-29
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sturm MBMatthew B
2Roday SSetu
3Schramm VLVern L

Source PubMed

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
DNA, CircularMajor topic
RNAMajor topic
RicinMajor topic
Cyclization
Drug Design
Kinetics
Nucleic Acid Hybridization
Oligonucleotides
Oximes
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization

Source PubMed

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R01 CA072444NCI NIH HHSUnited StatesR01CA072444PubMed and NIH
CA72444NCI NIH HHSUnited StatesR01CA072444PubMed and NIH

References19

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
110,896,793The effect of a monoclonal antibody coupled to ricin A chain-derived peptides on endothelial cells in vitro: insights into toxin-mediated vascular damage.Exp Cell Res2000https://conductscience.org/library/papers/10896793PubMed
215,766,271Ricin A-chain activity on stem-loop and unstructured DNA substrates.Biochemistry2005https://conductscience.org/library/papers/15766271PubMed
311,596,939Highly efficient synthesis of peptide-oligonucleotide conjugates: chemoselective oxime and thiazolidine formation.Chemistry2001https://conductscience.org/library/papers/11596939PubMed
412,370,937Efficient and simple solid-phase synthesis of short cyclic oligodeoxynucleotides bearing a phosphorothioate linkage.Angew Chem Int Ed Engl2002https://conductscience.org/library/papers/12370937PubMed
514,575,507Head-to-tail oxime cyclization of oligodeoxynucleotides for the efficient synthesis of circular DNA analogues.J Org Chem2003https://conductscience.org/library/papers/14575507PubMed
615,109,249Ricin A-chain substrate specificity in RNA, DNA, and hybrid stem-loop structures.Biochemistry2004https://conductscience.org/library/papers/15109249PubMed
715,109,250Inhibition of ricin A-chain with pyrrolidine mimics of the oxacarbenium ion transition state.Biochemistry2004https://conductscience.org/library/papers/15109250PubMed
83,571,242The mechanism of action of ricin and related toxic lectins on eukaryotic ribosomes. The site and the characteristics of the modification in 28 S ribosomal RNA caused by the toxins.J Biol Chem1987https://conductscience.org/library/papers/3571242PubMed
93,288,622The RNA N-glycosidase activity of ricin A-chain. The characteristics of the enzymatic activity of ricin A-chain with ribosomes and with rRNA.J Biol Chem1988https://conductscience.org/library/papers/3288622PubMed
101,379,305Ribosomal RNA identity elements for ricin A-chain recognition and catalysis. Analysis with tetraloop mutants.J Mol Biol1992https://conductscience.org/library/papers/1379305PubMed
117,544,462Synthesis, deprotection, analysis and purification of RNA and ribozymes.Nucleic Acids Res1995https://conductscience.org/library/papers/7544462PubMed
129,000,624A network of heterogeneous hydrogen bonds in GNRA tetraloops.J Mol Biol1996https://conductscience.org/library/papers/9000624PubMed
139,037,714Ricin A-chain structural determinant for binding substrate analogues: a molecular dynamics simulation analysis.Proteins1997https://conductscience.org/library/papers/9037714PubMed
149,383,473Synthesis and biochemical evaluation of RNA containing an intrahelical disulfide crosslink.Chem Biol1995https://conductscience.org/library/papers/9383473PubMed
159,711,915Clinical trials with an anti-CD25 ricin A-chain experimental and immunotoxin (RFT5-SMPT-dgA) in Hodgkin's lymphoma.Leuk Lymphoma1998https://conductscience.org/library/papers/9711915PubMed
169,708,998Ricin A-chain: kinetics, mechanism, and RNA stem-loop inhibitors.Biochemistry1998https://conductscience.org/library/papers/9708998PubMed
179,876,120Free energy determinants of binding the rRNA substrate and small ligands to ricin A-chain.Biophys J1999https://conductscience.org/library/papers/9876120PubMed
1810,097,145Evidence for a structural motif in toxins and interleukin-2 that may be responsible for binding to endothelial cells and initiating vascular leak syndrome.Proc Natl Acad Sci U S A1999https://conductscience.org/library/papers/10097145PubMed
1911,259,830Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings.Adv Drug Deliv Rev2001https://conductscience.org/library/papers/11259830PubMed

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 33 citations.

PMIDTitleJournalYearIn PapersSource
41,828,800Biological Nanoscaffolds from Hierarchical Construction to Applications.Molecules2026https://conductscience.org/library/papers/41828800PubMed
39,525,953Synthetic circRNA therapeutics: innovations, strategies, and future horizons.MedComm (2020)2024https://conductscience.org/library/papers/39525953PubMed
36,729,328Targeting the Inside of Cells with Biologicals: Toxin Routes in a Therapeutic Context.BioDrugs2023https://conductscience.org/library/papers/36729328PubMed
35,390,188Isomorphic Fluorescent Nucleosides Facilitate Real-Time Monitoring of RNA Depurination by Ribosome Inactivating Proteins.Chemistry2022https://conductscience.org/library/papers/35390188PubMed
32,428,396Small Molecule Inhibitors Targeting the Interaction of Ricin Toxin A Subunit with Ribosomes.ACS Infect Dis2020https://conductscience.org/library/papers/32428396PubMed
30,335,982Enzymatic Transition States and Drug Design.Chem Rev2018https://conductscience.org/library/papers/30335982PubMed
30,023,541Iminosugars Spiro-Linked with Morpholine-Fused 1,2,3-Triazole: Synthesis, Conformational Analysis, Glycosidase Inhibitory Activity, Antifungal Assay, and Docking Studies.ACS Omega2017https://conductscience.org/library/papers/30023541PubMed
29,049,877Synthesis of 5'-Thio-3'-O-ribonucleoside Phosphoramidites.J Org Chem2017https://conductscience.org/library/papers/29049877PubMed
27,823,883Oligonucleotide transition state analogues of saporin L3.Eur J Med Chem2017https://conductscience.org/library/papers/27823883PubMed
27,668,458In vitro circularization of RNA.RNA Biol2017https://conductscience.org/library/papers/27668458PubMed
26,886,255Transition State Structure of RNA Depurination by Saporin L3.ACS Chem Biol2016https://conductscience.org/library/papers/26886255PubMed
26,478,835Advanced Developments in Cyclic Polymers: Synthesis, Applications, and Perspectives.ChemistryOpen2015https://conductscience.org/library/papers/26478835PubMed
26,091,305Soapwort Saporin L3 Expression in Yeast, Mutagenesis, and RNA Substrate Specificity.Biochemistry2015https://conductscience.org/library/papers/26091305PubMed
23,259,601Transition States, analogues, and drug development.ACS Chem Biol2013https://conductscience.org/library/papers/23259601PubMed
22,347,620Inhibitors of the cellular trafficking of ricin.Toxins (Basel)2012https://conductscience.org/library/papers/22347620PubMed
21,689,934Profiling base excision repair glycosylases with synthesized transition state analogs.Bioorg Med Chem Lett2011https://conductscience.org/library/papers/21689934PubMed
21,455,295Small-molecule inhibitor leads of ribosome-inactivating proteins developed using the doorstop approach.PLoS One2011https://conductscience.org/library/papers/21455295PubMed
19,920,175Transition state analogues in structures of ricin and saporin ribosome-inactivating proteins.Proc Natl Acad Sci U S A2009https://conductscience.org/library/papers/19920175PubMed
19,764,816Transition state analogues rescue ribosomes from saporin-L1 ribosome inactivating protein.Biochemistry2009https://conductscience.org/library/papers/19764816PubMed
18,683,267A highly emissive fluorescent nucleoside that signals the activity of toxic ribosome-inactivating proteins.Angew Chem Int Ed Engl2008https://conductscience.org/library/papers/18683267PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17417841

GET https://conductscience.org/api/papers/v1/17417841/authors